ATE514089T1 - Leukämie-diagnoseverfahren - Google Patents

Leukämie-diagnoseverfahren

Info

Publication number
ATE514089T1
ATE514089T1 AT07819698T AT07819698T ATE514089T1 AT E514089 T1 ATE514089 T1 AT E514089T1 AT 07819698 T AT07819698 T AT 07819698T AT 07819698 T AT07819698 T AT 07819698T AT E514089 T1 ATE514089 T1 AT E514089T1
Authority
AT
Austria
Prior art keywords
leukemia
level
15ralpha
amount
sample
Prior art date
Application number
AT07819698T
Other languages
English (en)
Inventor
Martin Stanulla
Gunnar Cario
Original Assignee
Hannover Med Hochschule
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hannover Med Hochschule filed Critical Hannover Med Hochschule
Application granted granted Critical
Publication of ATE514089T1 publication Critical patent/ATE514089T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07819698T 2006-11-08 2007-11-08 Leukämie-diagnoseverfahren ATE514089T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06023215A EP1921452A1 (de) 2006-11-08 2006-11-08 Methode zur Diagnose von Leukämie
PCT/EP2007/009689 WO2008055682A1 (en) 2006-11-08 2007-11-08 Method for the diagnosis of leukemia

Publications (1)

Publication Number Publication Date
ATE514089T1 true ATE514089T1 (de) 2011-07-15

Family

ID=37693521

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07819698T ATE514089T1 (de) 2006-11-08 2007-11-08 Leukämie-diagnoseverfahren

Country Status (4)

Country Link
US (1) US20100008930A1 (de)
EP (2) EP1921452A1 (de)
AT (1) ATE514089T1 (de)
WO (1) WO2008055682A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006306743A (ja) * 2005-04-26 2006-11-09 Hamamatsu Photonics Kk 体液処理方法
EP3468581A1 (de) 2016-06-13 2019-04-17 Torque Therapeutics, Inc. Verfahren und zusammensetzungen zur förderung der immunzellenfunktionen
EP3678701A4 (de) 2017-09-05 2021-12-01 Torque Therapeutics, Inc. Therapeutische proteinzusammensetzungen und verfahren zur herstellung und verwendung davon

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6001973A (en) * 1996-04-26 1999-12-14 Beth Israel Deaconess Medical Center Antagonists of interleukin-15
TW200619227A (en) * 2004-08-11 2006-06-16 Hoffmann La Roche Mutant interleukin-15-containing compositions and suppression of an immune response
AU2005335217A1 (en) * 2004-10-05 2007-02-15 Ochsner Clinic Foundation Enhancement of B cell proliferation by IL-15

Also Published As

Publication number Publication date
EP1921452A1 (de) 2008-05-14
WO2008055682A8 (en) 2008-07-17
WO2008055682A1 (en) 2008-05-15
EP2089716B1 (de) 2011-06-22
EP2089716A1 (de) 2009-08-19
US20100008930A1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
BRPI0515271A (pt) fixação de extremidade de correia para a fixação de uma extremidade de uma correia portadora em um sistema de elevador e método para a fixação de uma extremidade de uma correia portadora em um sistema de elevador
DE602005012969D1 (de) Verfahren zur vergrösserung der positionsverfügbarkeit
DE602004009247D1 (de) Zweiteilige Halteklammer für Kraftstoff bzw. Bremsleitungen
NO20063624L (no) FC region varianter
BRPI0503383A (pt) instalação de elevador com um carro e um dispositivo para determinar uma posição de carro e método para operar tal instalação de elevador
BRPI0519570A2 (pt) mÉtodo de determinaÇço de faixa de dose de uma warfarina para um indivÍduo, kit para determinaÇço da faixa de dose de uma warfarina, oligonucleotÍdeo ou complemento do mesmo, e, arranjo de oligonucleotÍdeos
MX2009013649A (es) Variantes geneticas en el cromosoma 15q24 como marcadores para usarse en diagnostico, prognosis y tratamiento de sindrome de exfoliacion y glaucoma.
ATE531820T1 (de) Gesundheitszustandstest
EA200970695A1 (ru) Способы и нуклеиновые кислоты для анализов нарушений клеточной пролиферации
EP2212700B8 (de) Verfahren zur beurteilung von kolorektalem krebs anhand einer stuhlprobe durch verwendung einer marker-kombination aus calprotectin und einem hämoglobin/haptoglobin-komplex
PL2220492T3 (pl) Polimorfizmy VEGF oraz terapia antyangiogenna
ECSP088316A (es) Moduladores sustituidos de 3-amido-tetrahidro-indazolil cannabinoide
WO2007092487A3 (en) Materials and methods for identifying agents that modulate norrin. norrin mimetics, and agents identified thereby
ATE514089T1 (de) Leukämie-diagnoseverfahren
WO2009007649A3 (fr) Dispositif et procede d'identification et de determination de groupes sanguins
BRPI0813293A2 (pt) Método para determinar a qualidade de uma amostra de fluido de fundo de poço, e mídia legível por computador.
DE602007010644D1 (de) Biomarker zur beurteilung der leberfunktion
FR2937139B1 (fr) Dispositif de determination de la concentration en monoxyde de carbone et procede.
ATE552438T1 (de) Verschleissanzeiger mit temperatursensor
CL2008001837A1 (es) Uso de compuestos derivados de cinolin-3-carboxamida en el tratamiento de la esquizofrenia.
MX2009005400A (es) Metodo para el diagnostico y tratamiento del glioma.
DE60316153D1 (de) Chemilumineszenz-nachweisverfahren
DE602005013403D1 (de) Verfahren für den nachweis von streptococcus agalactiae mittels alpha-glucosidase-aktivität
BRPI0908054A2 (pt) Ajustador de folga, e, retentor de esfera
DE112005000270D2 (de) Fahrzeugsensor zur Erfassung von Körperschall

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties